Your browser doesn't support javascript.
loading
Montrer: 20 | 50 | 100
Résultats 1 - 3 de 3
Filtre
Ajouter des filtres








Gamme d'année
1.
National Journal of Andrology ; (12): 201-205, 2007.
Article Dans Chinois | WPRIM | ID: wpr-297755

Résumé

<p><b>OBJECTIVE</b>To investigate the effects of adenovirus-mediated PTEN and P27 on the invasion of PC-3 in vitro and angiogenesis, along with their synergy in the treatment of prostate cancer.</p><p><b>METHODS</b>Recombinant adenovirus vectors of the human tumor suppressor genes PTEN and P27 were constructed. The replication-incompetent recombinant adenovirus was packaged and propagated in HEK293 cells. The viral titer was examined by plaque assay and the mRNA and protein expressions of PTEN and P27 in human prostate cancer cell line PC-3 infected with Ad-PTEN and Ad-P27 were determined by RT-PCR and Western blot respectively. The invasion of PC-3 cells in vitro was examined by Boyden chamber assay. MTT assay was used to testify the effect of supernatant from PC-3 infected with Ad-PTEN and Ad-P27 on the proliferation of endothelial cells ECV-304 and the CAM test was used to testify the effect of PTEN and P27 on angiogenesis. The difference between the combined therapy group and the single gene therapy group was also examined.</p><p><b>RESULTS</b>The viral titers of Ad-PTEN and Ad-P27 were 1.8 x 10(7) pfu/ml and 1.2 x 10(9) pfu/ml respectively. Adenovirus infection verified that the mRNA and protein expression of PTEN and P27 were steady in human PC-3 cells. The invasion in vitro of PC-3 cells was significantly inhibited by infection with Ad-PTEN or/and Ad-P27. CAM and MTT assays of ECV-304 confirmed that the supernatant from PC-3 cells infected with Ad-PTEN or/and Ad-P27 could inhibit the angiogenesis effectively. There was a significant difference between the combined therapy group and the single gene therapy group.</p><p><b>CONCLUSION</b>The combined gene therapy of Ad-PTEN and Ad-P27 plays a synergistic role in inhibiting the invasiveness of PC-3 cells and angiogenesis.</p>


Sujets)
Humains , Mâle , Adenoviridae , Génétique , Lignée cellulaire tumorale , Inhibiteur p27 de kinase cycline-dépendante , Génétique , Invasion tumorale , Phosphohydrolase PTEN , Génétique , Tumeurs de la prostate , Anatomopathologie , Transfection
2.
China Journal of Chinese Materia Medica ; (24): 63-66, 2005.
Article Dans Chinois | WPRIM | ID: wpr-276643

Résumé

<p><b>OBJECTIVE</b>The purpose of the present study was to investigate the in vitro effects of baicalin on induction of apoptosis in human prostate cancer cell line DU145.</p><p><b>METHOD</b>Human prostate cancer cell line DU145 was treated with different concentration of baicalin in vitro. The apoptosis rate was determined by FACS analysis, cell cycle distribution was detected by flow cytometry, morphological changes and protein analysis were determined by means of electron microscope techniqueand immunohistochemical techniquerespectively.</p><p><b>RESULT</b>50micromol x L(-1) and 125 micromol x L(-1) of baicalin dose-dependently induced apoptosis and inhibited the proliferation of prostate cancer cell DU145 in a dose and time-dependent manner. DNA flow cytometric analysis indicated that baicalin induced a arrest in G1 phase, showing a typical apoptosis peak. Electron microscopy detected a characteristic appearance of the apoptotic cells morphology. Immunohistochemical analysis revealed that induction of apoptosis by ways of inhibition of the bcl-2, loss of the Bax, and upregulation of Fas.</p><p><b>CONCLUSION</b>The results indicate that baicalin may induce apoptosis and inhibit proliferation of prostate cancer cells, and has direct anti-tumor effects on human prostate cancer cells.</p>


Sujets)
Humains , Mâle , Antinéoplasiques d'origine végétale , Pharmacologie , Apoptose , Lignée cellulaire tumorale , Prolifération cellulaire , Relation dose-effet des médicaments , Flavonoïdes , Pharmacologie , Phase G1 , Plantes médicinales , Chimie , Tumeurs de la prostate , Métabolisme , Anatomopathologie , Protéines proto-oncogènes c-bcl-2 , Métabolisme , Scutellaria , Chimie , Protéine Bax , Antigènes CD95 , Métabolisme
3.
Chinese Journal of Surgery ; (12): 600-603, 2004.
Article Dans Chinois | WPRIM | ID: wpr-299892

Résumé

<p><b>OBJECTIVES</b>To investigate whether the human PC-3 cell infected with recombinant Ad-PTEN and Ad-p27Kip1 can steadily produce PTEN and p27Kip1 protein and change the biologic behaviors such as cell proliferation, cell cycle and apoptosis. The synergistic effect of PTEN and p27Kip1 on the therapy for prostate cancer has also been investigated.</p><p><b>METHODS</b>We constructed recombinant adenovirus vector of human tumor suppressor gene PTEN and p27Kip1. The viral titer was examined by plaque assay and the mRNA and protein expressions of PTEN and p27Kip1 in human prostate cancer cell line PC-3 infected with Ad-PTEN and Ad-p27Kip1 were determined by RT-PCR and Western blot respectively. MTT assay was used to determine the effect of PTEN and p27Kip1 on growth and proliferation of PC-3 cell; the change of cell cycle and apoptosis was examined by flow cytometry, and to compare between the combined therapy group and single gene therapy group.</p><p><b>RESULTS</b>The viral titers of Ad-PTEN and Ad-p27Kip1 were 1.8 x 10(7) pfu/ml and 1.2 x 10(9) pfu/ml respectively. After infected by adenovirus, it had been verified that the mRNA and protein expression of PTEN and p27Kip1 were steady in human PC-3 cell. Ad-PTEN and Ad-p27 Kip1 inhibited the growth and proliferation of PC-3 cells. The progression of cell cycle of PC-3 cell was arrested in G(0)-G(1) phase, meanwhile the apoptosis rate of PC-3 was also affected after Ad-PTEN or/and Ad-p27 Kip1 infected. There was significant difference between combined therapy group and single gene therapy group.</p><p><b>CONCLUSION</b>The recombinant Ad-PTEN and Ad-p27Kip1 vector were constructed successfully and the expression of specific PTEN and p27Kip1 was high, steadily in PC-3 cell line. These results suggested that combination of PTEN with p27Kip1 has an application value in treatment of prostate cancer in future.</p>


Sujets)
Humains , Mâle , Adenoviridae , Génétique , Apoptose , Division cellulaire , Lignée cellulaire tumorale , Chromosomes humains de la paire 10 , Génétique , Inhibiteur p27 de kinase cycline-dépendante , Délétion de gène , Thérapie génétique , Vecteurs génétiques , Protéines et peptides de signalisation intracellulaire , Génétique , Pharmacologie , Phosphohydrolase PTEN , Génétique , Pharmacologie , Tumeurs de la prostate , Génétique , Thérapeutique , Transfection
SÉLECTION CITATIONS
Détails de la recherche